Palbociclib: An Evidence-Based Review of Its Potential in the Treatment of Breast Cancer

Breast Cancer: Targets and Therapy - New Zealand
doi 10.2147/bctt.s46725
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

Lixivaptan &Ndash; An Evidence-Based Review of Its Clinical Potential in the Treatment of Hyponatremia

Core Evidence
MedicineReviewsReferencesPharmacology
2013English

Profile of Buparlisib and Its Potential in the Treatment of Breast Cancer: Evidence to Date [Corrigendum]

Breast Cancer: Targets and Therapy
Oncology
2018English

Palbociclib in Metastatic Breast Cancer: Current Evidence and Real-Life Data

Drugs in Context
Molecular MedicinePharmacology
2019English

Profile of Abemaciclib and Its Potential in the Treatment of Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2018English

Pcn3 - Real World Evidence of Metastatic Breast Cancer Treatment: A Comparison of Adverse Effects Between Palbociclib Treatment and Endocrine Therapy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Capecitabine: An Evidence-Based Review of Its Effectiveness in the Treatment of Carcinoma of the Pancreas

Core Evidence
MedicineReviewsReferencesPharmacology
2007English

Palbociclib: First CDK4/6 Inhibitor in Clinical Practice for the Treatment of Advanced HR-Positive Breast Cancer

Breast Care
SurgeryOncology
2016English

Phytocannabis for the Treatment of Cancer-Related or Cancer Treatment Related Symptoms: Evidence Based Review

TEXILA INTERNATIONAL JOURNAL OF CLINICAL RESEARCH
2016English

Evidence for the Role of Bevacizumab in the Treatment of Advanced Metastatic Breast Cancer: A Review

Breast Cancer: Targets and Therapy
Oncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy